regional medical center: Stroke Survivors Benefit From Clot Buster

Senin, 28 Mei 2012

Stroke Survivors Benefit From Clot Buster

Stroke Survivors Benefit From Clot Buster

Featured Article
Academic Journal
Main Category: Stroke
Also Included In: Clinical Trials / Drug Trials
Article Date: 28 May 2012 - 2:00 PDT

email to a friend Â

printer friendly Â

opinions Â <!--

rate article
Patient / Public: not yet rated

Healthcare Prof: not yet rated

Results of an international trial show that stroke survivors make a better recovery if they are given the clot-busting drug rt-PA in the first six hours following a stroke.

Led by the University of Edinburgh in Scotland, the international trial, known as IST-3, found that for every 1,000 patients that received the clot-buster within the first three hours of a stroke, 80 more survive and live without help from others, compared to patients not receiving the drug.

The IST-3 collaborative group write about their findings in a paper that was published online in The Lancet on 23 May. Alongside the trial results they also present an analysis of all other drug trials of rt-PA conducted in the last 20 years.

IST-3 stands for the third International Stroke Trial. Its aim was to find out whether a wider range than hitherto of patients treated within the first 6 hours from stroke onset might benefit.

One of the IST-3 group members, Professor Peter Sandercock, is Chief Investigator at Edinburgh's Centre for Clinical Brain Sciences and Director of Edinburgh Neuroscience. He told the press:

"Our trial shows that it is crucial that treatment is given as fast as possible to all suitable patients."

Rt-PA (recombinant tissue plasminogen activator) is a clot-busting drug that is given intravenously to patients who have suffered an acute ischemic stroke, where a blood clot interrupts the blood supply to the brain.

The multi-centre, randomized study involved more than 3,000 patients enrolled in over 150 hospitals in 12 countries, and is the world's largest ever trial of rt-PA. Just over half the participants were over 80 years of age.

The damage from an ischemic stroke can be permanent or fatal. Symptoms of damage include paralysis down one side of the body and problems with speech.

But the benefits of rt-PA come at a price, said the researchers: there is a higher risk of death in the first seven days of treatment because the drug can cause a secondary bleed in the brain.

However, they conclude they saw the benefits in a wide range of patients, despite the risks. And, they pointed out, the higher risk of death from the drug needs to viewed in the context of deaths from stroke: without treatment, one third of stroke victims die, and another third are left permanently disabled and dependent on others.

Professor Joanna Wardlaw of the University of Edinburgh's Centre for Clinical Brain Sciences, led the IST-3 Imaging team. She said:

"We have looked at data from more than 7,000 stroke patients worldwide. What we see is that the drug increases patients' longer term recovery. But we need to find out why some people bleed and how to reduce this to increase the effectiveness of clot busting treatment."

Support for the UK-based work came from the Medical Research Council, the Stroke Association UK, the Health Foundation UK, NIHR Stroke Research Network and NHS Lothian Health Board. Other groups in other countries, including Sweden, Norway, Australia, Poland, Italy and Switzerand also received funds from various state, academic and charitable bodies.

Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Additional

References

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

APA

Please note: If no author information is provided, the source is cited instead.

Add Your Opinion On This Article

'Stroke Survivors Benefit From Clot Buster'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

regional medical center

Senin, 28 Mei 2012

Stroke Survivors Benefit From Clot Buster

Add Your Opinion On This Article

Tidak ada komentar:

Posting Komentar